Evidence map›Paper›PMID 38257297›Full record

ArticleMolecules (Basel, Switzerland)2024

Aigerim Kantureyeva, Gulbaram Ustenova, Alenka Zvonar Pobirk, Serzhan Mombekov, Moldir Koilybayeva, Akerke Amirkhanova, Nadezhda Gemejiyeva, Assem Mamurova, Nina Kočevar Glavač

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Aigerim KantureyevaSchool of Pharmacy, S.D. Asfendiyarov Kazakh National Medical University, Tole-bi 94, Almaty 050012, Kazakhstan.ORCID 0000-0001-7080-6227
Gulbaram UstenovaSchool of Pharmacy, S.D. Asfendiyarov Kazakh National Medical University, Tole-bi 94, Almaty 050012, Kazakhstan.ORCID 0000-0003-2961-5730
Alenka Zvonar PobirkDepartment of Pharmaceutical Technology, Faculty of Pharmacy, University of Ljuljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia.ORCID 0000-0003-4886-0168
Serzhan MombekovSchool of Pharmacy, S.D. Asfendiyarov Kazakh National Medical University, Tole-bi 94, Almaty 050012, Kazakhstan.
Moldir KoilybayevaSchool of Pharmacy, S.D. Asfendiyarov Kazakh National Medical University, Tole-bi 94, Almaty 050012, Kazakhstan.ORCID 0000-0002-8401-9977
Akerke AmirkhanovaSchool of Pharmacy, S.D. Asfendiyarov Kazakh National Medical University, Tole-bi 94, Almaty 050012, Kazakhstan.ORCID 0000-0003-1479-3171
Nadezhda GemejiyevaLaboratory of Plant Resources, Institute of Botany and Phyto-Introductions, Almaty 050000, Kazakhstan.ORCID 0000-0002-7317-2685
Assem MamurovaDepartment of Biodiversity of Bioresources, al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.ORCID 0000-0002-4676-9443
Nina Kočevar GlavačDepartment of Pharmaceutical Biology, Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia.
Kazakh National Medical University · KZUniversity of Ljubljana · SIAl-Farabi Kazakh National University · KZInstitute of Plant Biology and Biotechnology · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsChenopodiaceaeAnimalsArtemiaAsia, EasternMineralsAntineoplastic AgentsMineralsanatomyCeratocarpus arenariusChenopodiaceaecytotoxic activitymineral contentproximate composition

Identifiers

PMID38257297
PMCPMC10819601
OpenAlexW4390827986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.